News
-
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth
Zomedica Corp. reports record third-quarter revenue growth of 10%, driven by strong performance in Diagnostics and Capital segments. International expansion and positive outlook for 2025 highlighted by CEO Larry Heaton -
-
-
-
-
-
-